Back to News
Market Impact: 0.28
Quest Diagnostics Sees Growth Outpace Targets as Consumer Testing Surges
Source: marketbeat.com
Company FundamentalsCorporate Guidance & OutlookHealthcare & BiotechConsumer Demand & RetailM&A & Restructuring
Quest Diagnostics CEO Jim Davis said the company is exceeding the growth framework presented at its previous investor day. Growth is being led by organic expansion, consumer-health demand and partnerships, rather than a more aggressive-than-expected acquisition pace. The comments indicate favorable operating momentum and reduced reliance on M&A to meet growth objectives.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.42
Ticker Sentiment
DGX0.62
More News
- Why is Labcorp stock sliding today?
- Why is Quest Diagnostics stock sliding today?
- Taiwan benchmark Taiex rises to record intraday high as tech stocks advance
- AMD joins the $1 trillion club as chip rally surges - our AI Strategy saw it early
- Paramount agrees invest $1.5 billion in domestic movies and create a board for editorial independence at CNN, CBS as part of deal for Warner Bros.
- Paramount and state AGs will settle lawsuit, allowing Warner Bros. merger to proceed, reports say